Gene · 10562
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation. | Cells | 2025 | 41002392 | PubTator, text mining | PubMed |
| Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer. | Signal Transduct Target Ther | 2025 | 40976783 | PubTator, text mining | PubMed |
| Identification of Colorectal Cancer-Associated Protein Signatures in Small Extracellular Vesicles Based on Proteomics. | J Proteome Res | 2025 | 40960359 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts shape the formation of budding cancer cells at the invasive front of human colorectal cancer. | Commun Biol | 2025 | 40957874 | PubTator, text mining | PubMed |
| A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules. | bioRxiv | 2025 | 40949972 | PubTator, text mining | PubMed |
| NFATc3 and PML synergistically regulate tumor-associated gene expression in a SUMOylation-Independent manner. | Biochimie | 2025 | 40930486 | PubTator, text mining | PubMed |
| Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer. | Front Oncol | 2025 | 40900789 | PubTator, text mining | PubMed |
Mechanistic Insights into the Effects of Liquid Crystalline Monomers on Intestinal Stem Cell Differentiation Imbalance by Integrating Machine Learning and Adverse Outcome Pathway Framework Based on Organoids. | Environ Sci Technol | 2025 | 40878620 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived lncRNA-GC1 serves as a novel biomarker for predicting and monitoring the immunotherapeutic outcomes of patients with gastric cancer. | BMC Med | 2025 | 40866962 | PubTator, text mining | PubMed |
| Wound-healing biodegradable microparticles: an in vitro investigation. | Biomater Sci | 2025 | 40856239 | PubTator, text mining | PubMed |
| The impact of ageing on the structural compositions of the mucosa of human colon. | Tissue Cell | 2025 | 40848414 | PubTator, text mining | PubMed |
| Reconstitution of T cell-mediated immunity by umbilical cord-derived mesenchymal stem cells in ulcerative colitis. | Clin Transl Med | 2025 | 40842289 | PubTator, text mining | PubMed |
| Unveiling the protein landscape for early detection of colorectal precancerous lesions. | Clin Proteomics | 2025 | 40841878 | PubTator, text mining | PubMed |
| Olfactomedin 4 in cancer development and progression. | Biochim Biophys Acta Rev Cancer | 2025 | 40835069 | PubTator, text mining | PubMed |
| Incorporating Active Learning and Inclusive Practices in a Flipped Environment: Findings from Introductory Chemistry at a Hispanic Serving Institution. | J Chem Educ | 2025 | 40822670 | PubTator, text mining | PubMed |
| Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy. | Genes Dis | 2025 | 40808876 | PubTator, text mining | PubMed |
| Wnt5a suppresses colorectal cancer progression via TGF-β/NOTUM/OLFM4 axis in patient-derived organoids. | Cell Commun Signal | 2025 | 40765051 | PubTator, text mining | PubMed |
| Diagnostic value of lnc-RNAs TINCR, GC1 and AFAP1-AS1 in gastric cancer differentiation from healthy people. | Biomark Med | 2025 | 40762454 | PubTator, text mining | PubMed |
| Identification of a stromal immunosuppressive barrier orchestrated by SPP1+/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance. | Front Immunol | 2025 | 40740771 | PubTator, text mining | PubMed |
| Exosomal ncRNAs in liquid biopsy: a new paradigm for early cancer diagnosis and monitoring. | Front Oncol | 2025 | 40703556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10562/papers?page=4